Parkman Healthcare Partners’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-65,050
| Closed | -$2.06M | – | 100 |
|
|
2023
Q3 | $2.06M | Buy |
65,050
+2,640
| +4% | +$83.4K | 0.38% | 71 |
|
|
2023
Q2 | $1.61M | Buy |
62,410
+292
| +0.5% | +$7.55K | 0.28% | 82 |
|
|
2023
Q1 | $1.49M | Buy |
62,118
+9,364
| +18% | +$225K | 0.32% | 67 |
|
|
2022
Q4 | $1.03M | Buy |
52,754
+10,359
| +24% | +$202K | 0.27% | 72 |
|
|
2022
Q3 | $891K | Buy |
42,395
+10,381
| +32% | +$218K | 0.25% | 75 |
|
|
2022
Q2 | $623K | Buy |
32,014
+1,660
| +5% | +$32.3K | 0.23% | 66 |
|
|
2022
Q1 | $668K | Buy |
+30,354
| New | +$668K | 0.2% | 73 |
|